EasyNAT Rapid RSV Assay
Ongoing Challanges
Respiratory Syncytial Virus (RSV) leads to approximately 3.2 million hospitalizations and 160,000 deaths annually worldwide, with a significant proportion occurring in children under five years old.[1]
RSV can cause severe illnesses such as bronchiolitis and pneumonia. It is the most common cause of bronchiolitis and pneumonia in children under one year of age.[2]
Traditional diagnostic methods often lack sensitivity and may produce false-negative results, especially in cases with low viral loads.
Product Overview
This assay is an automated, in vitro nucleic acid amplification test for the qualitative detection of Respiratory Syncytial Virus (RSV) in oropharyngeal swab samples from individuals suspected of having a respiratory infection.
Accurate test results within 33 minutes
Accurate LOD: 100 copies/mL
Significantly reduces the incidence of false negatives compared to traditional methods
Clinical Value
Optimizes the testing experience, providing accurate results even with low viral loads.
Enables precise and timely treatment, facilitating large-scale screening in pediatric wards, neonatal wards, ICUs, and emergency rooms.
Significantly reduces the incidence of false negatives compared to traditional methods.
